|
1
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H
and Zou X: Report of cancer incidence and mortality in China, 2010.
Ann Transl Med. 2:612014.PubMed/NCBI
|
|
2
|
Fock KM: Review article: The epidemiology
and prevention of gastric cancer. Aliment Pharmacol Ther.
40:250–260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mikuriya Y, Tashiro H, Kuroda S, Nambu J,
Kobayashi T, Amano H, Tanaka Y and Ohdan H: Fatty liver creates a
pro-metastatic microenvironment for hepatocellular carcinoma
through activation of hepatic stellate cells. Int J Cancer.
136:E3–E13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu Q, Shan H and Zhu Z: Regulation of
epithelial-mesenchymal transition by MACC1 via the HGF/c-Met
signaling pathway and its effects on ability of migration and
invasion of gastric carcinoma cells. J Shanghai Jiaotong Univ (Med
Sci). 34:1325–1331. 2014.
|
|
5
|
Xie QP, Xiang C, Wang G, Lei KF and Wang
Y: MACC1 upregulation promotes gastric cancer tumor cell metastasis
and predicts a poor prognosis. J Zhejiang Univ Sci B. 17:361–366.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stein U, Dahlmann M and Walther W:
MACC1-more than metastasis? Facts and predictions about a novel
gene. J Mol Med (Berl). 88:11–18. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang L, Wu Y, Lin L, Liu P, Huang H, Liao
W, Zheng D, Zuo Q, Sun L, Huang N, et al: Metastasis-associated in
colon cancer-1 upregulation predicts a poor prognosis of gastric
cancer, and promotes tumor cell proliferation and invasion. Int J
Cancer. 133:1419–1430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang G, Fu Z and Li D: MACC1
overexpression and survival in solid tumors: A meta-analysis.
Tumour Biol. 36:1055–1065. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Navidshad B, Liang JB and Jahromi MF:
Correlation coefficients between different methods of expressing
bacterial quantification using real time PCR. Int J Mol Sci.
13:2119–2132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sobrevals L, Enguita M, Quiroga J, Prieto
J and Fortes P: Insulin-like growth factor I (IGF-I) expressed from
an AAV1 vector leads to a complete reversion of liver cirrhosis in
rats. PLoS One. 11:e01629552016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stein U, Walther W, Arlt F, Schwabe H,
Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ge Y, Meng X, Zhou Y, Zhang J and Ding Y:
Positive MACC1 expression correlates with invasive behaviors and
postoperative liver metastasis in colon cancer. Int J Clin Exp Med.
8:1094–1100. 2015.PubMed/NCBI
|
|
13
|
Li H, Zhang H, Zhao S, Shi Y, Yao J, Zhang
Y, Guo H and Liu X: Overexpression of MACC1 and the association
with hepatocyte growth factor/c-Met in epithelial ovarian cancer.
Oncol Lett. 9:1989–1996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shirahata A, Shinmura K, Kitamura Y,
Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K,
Kigawa G, et al: MACC1 as a marker for advanced colorectal
carcinoma. Anticancer Res. 30:2689–2692. 2010.PubMed/NCBI
|
|
15
|
Shirahata A, Fan W, Sakuraba K, Yokomizo
K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, et
al: MACC 1 as a marker for vascular invasive hepatocellular
carcinoma. Anticancer Res. 31:777–780. 2011.PubMed/NCBI
|
|
16
|
Tang J, Chen JX, Chen L, Tang JY, Cui Z,
Liu CH and Wang Z: Metastasis associated in colon cancer 1 (MACC1)
promotes growth and metastasis processes of colon cancer cells. Eur
Rev Med Pharmacol Sci. 20:2825–2834. 2016.PubMed/NCBI
|
|
17
|
Zhu M, Xu Y, Mao X, Gao Y, Shao L and Yan
F: Overexpression of metastasis-associated in colon cancer-1
associated with poor prognosis in patients with esophageal cancer.
Pathol Oncol Res. 19:749–753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yanagihara K, Takigahira M, Kubo T, Ochiya
T, Hamaguchi T and Matsumura Y: Marked antitumor effect of NK012, a
SN-38-incorporating micelle formulation, in a newly developed mouse
model of liver metastasis resulting from gastric cancer. Ther
Deliv. 5:129–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rink M, Chun FK, Robinson B, Sun M,
Karakiewicz PI, Bensalah K, Fisch M, Scherr DS, Lee RK, Margulis V
and Shariat SF: Tissue-based molecular markers for renal cell
carcinoma. Minerva Urol Nefrol. 63:293–308. 2011.PubMed/NCBI
|
|
20
|
Chen S, Zong ZH, Wu DD, Sun KX, Liu BL and
Zhao Y: The role of metastasis-associated in colon cancer 1 (MACC1)
in endometrial carcinoma tumorigenesis and progression. Mol
Carcinog. 56:1361–1371. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding Y, Li X, Hong D, Jiang L, He Y and
Fang H: Silence of MACC1 decreases cell migration and invasion in
human malignant melanoma through inhibiting the EMT. Biosci Trends.
10:258–264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo T, Yang J, Yao J, Zhang Y, Da M and
Duan Y: Expression of MACC1 and c-Met in human gastric cancer and
its clinical significance. Cancer Cell Int. 13:1212013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C,
Wang L, Wang J and Yuan Y: Identification of MACC1 as a novel
prognostic marker in hepatocellular carcinoma. J Transl Med.
9:1662011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang L, Lin L, Chen X, Sun L, Liao Y,
Huang N and Liao W: Metastasis-associated in colon cancer-1
promotes vasculogenic mimicry in gastric cancer by upregulating
TWIST1/2. Oncotarget. 6:11492–11506. 2015.PubMed/NCBI
|
|
25
|
Toiyama Y, Yasuda H, Saigusa S, Matushita
K, Fujikawa H, Tanaka K, Mohri Y, Inoue Y, Goel A and Kusunoki M:
Co-expression of hepatocyte growth factor and c-Met predicts
peritoneal dissemination established by autocrine hepatocyte growth
factor/c-Met signaling in gastric cancer. Int J Cancer.
130:2912–2921. 2012. View Article : Google Scholar : PubMed/NCBI
|
